Help patients who
have had a recent
worsening heart
failure event stay alive
and out of hospital
Help patients who
have had a recent
worsening heart
failure event stay alive
and out of hospital
Help patients who
have had a recent
worsening heart
failure event stay alive
and out of hospital
Discover sGC stimulation as a new mechanism in HF treatment
VERQUVO provides a novel HF therapy that has demonstrated powerful reductions in the composite of CV death and HF hospitalization compared to background therapies alone.
In patients with chronic HF after a worsening event, VERQUVO reduced the absolute risk of CV death and HF hospitalization combined by 4.2% (ARR) compared to background therapy alone.
In only 10.8 months, VERQUVO reduced the combined relative risk of CV death and HF hospitalization by 10% (RRR) in chronic HF patients following a worsening HF event.
Treating just 24 chronic HF patients with VERQUVO for one year can prevent one HF hospitalization, or even save a life (NNT 24).
CV death and HFH combined
VERQUVO provided significant risk reduction in patients with NT-proBNP levels frequently seen in clinical practice
For your chronic HFrEF patients who have had a worsening HF event, consider the role that once daily VERQUVO can play to reduce the risk of another event, hospitalization or CV death.
Reduce the combined risk of death from any cause or rehospitalization following a worsening HF event with VERQUVO
Patients with chronic HF need new therapies to further reduce their risk, whilst delivering a reassuring safety profile.
Improve your patients' chances of staying alive and out of hospital following a worsening HF event by adopting a therapy that will significantly reduce their risk of another event.
Adapted from Greene SJ et al. JAMA Cardiol 2018;3(3):252–259
Worsening HF event risk signals a need for treatment modification
Did your patient need time in hospital or additional treatment like IV diuretics? They may have suffered a worsening HF event.
Following a worsening HF event, patients are at even higher risk of cardiovascular disease and re-hospitalization
They experience a devastating cycle of escalating symptoms and frequent hospitalizations, which severely affects their lives as well as the lives of their loved ones.
